If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
108.50    -2.50 (-2.25%)
Bid:
107.00
Ask:
110.00
Spread: 3.00 (2.804%)
Market Cap: £14.63m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Awards under Long Term Incentive Plan

10 Jan 2013 07:01

RNS Number : 2205V
Revolymer PLC
10 January 2013
 



10th January 2013

Revolymer plc

("Revolymer" or "the Group")

Awards under Long Term Incentive Plan

 

Revolymer (AIM: REVO), the British polymer company developing patented products for a number of high value fast moving consumer goods ("FMCG") and industrial markets, announces the grant on 9 January 2013 of awards under the Revolymer plc Long Term Incentive Plan ("LTIP") to executive directors.

 

The LTIP was adopted by the board of directors of Revolymer plc (the "Board") on 29 June 2012 and its remuneration committee has approved the following grants to executive directors on 9 January 2013:

 

- To the CEO Roger Pettman a nil cost option over 281,690 ordinary shares

- To the CFO Robin Cridland a nil cost option over 253,521 ordinary shares

 

The vesting period of these grants is three years and they only become exercisable if challenging performance conditions are met; namely that 50% of the grant becomes exercisable if the weighted average ordinary share price in the 30 day period ending on the third anniversary of grant is 125p. Between weighted average ordinary share prices of 125p and 150p, vesting shall be pro-rata and on a straight line basis between 50% and 100%. Below 125p the grants are not exercisable and lapse in full.

The Board also requires the executive directors to maintain minimum interests (of at least 400,000 ordinary shares for Roger Pettman and 360,000 ordinary shares for Robin Cridland) before selling any ordinary shares that are the result of exercise, except that they may sell that number of ordinary shares that are required to satisfy any income tax and employee's national insurance liabilities arising at exercise. This requirement shall not apply on a change of control, or other transaction with substantially the same effect.

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Simon Rigby / David Dible / Ginny Pulbrook

 

 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the coatings & adhesives, household products and personal care markets (together "Consumer Specialties") and the confectionery chewing gum and medicated chewing gum (together "Gum") markets.

 

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBLMTTMBBMTTJ
Date   Source Headline
20th May 20197:00 amRNSBoard Change
3rd May 20197:00 amRNSFirst European Order for New Detergent Polymer
2nd Apr 20194:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20192:05 pmRNSSecond Price Monitoring Extn
28th Feb 20192:00 pmRNSPrice Monitoring Extension
28th Feb 20199:00 amRNSPersonal care agreement with Nouryon
18th Feb 201911:06 amRNSSecond Price Monitoring Extn
18th Feb 201911:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSFull Year Trading Update
15th Jan 20194:40 pmRNSSecond Price Monitoring Extn
15th Jan 20194:35 pmRNSPrice Monitoring Extension
15th Jan 20199:00 amRNSDetergent polymer agreement with Nouryon
9th Jan 20192:20 pmRNSBlock listing Interim Review
5th Dec 20187:00 amRNSNew Licence Agreement with New Wave
26th Oct 20187:00 amRNSDirectorate Change
2nd Oct 20187:00 amRNSBoard Changes
27th Sep 20187:00 amRNSInterim results
9th Aug 20181:41 pmRNSResult of AGM
6th Aug 20187:00 amRNSAppointment of Interim Chief Financial Officer
3rd Aug 20188:51 amRNSDirector/PDMR Dealings
3rd Aug 20188:47 amRNSBoard Changes
2nd Aug 201812:49 pmRNSExercise of Options, Directors' Dealing & TVR
2nd Aug 201811:57 amRNSResult of General Meeting
1st Aug 201810:02 amRNSResult of Open Offer & US Additional Subscription
16th Jul 20187:30 amRNSRestoration - Itaconix plc
13th Jul 20183:58 pmRNSReplacement re Further Details on the Fundraising
13th Jul 20183:54 pmRNSBlock listing Interim Review
13th Jul 20183:26 pmRNSRestoration of Trading
13th Jul 201812:11 pmRNSPosting of Circular & Annual Report & Notice of GM
12th Jul 20184:47 pmRNSFurther Details on the Fundraising
12th Jul 20187:05 amRNSProposed Fundraising
12th Jul 20187:00 amRNSPreliminary Results
29th Jun 20187:30 amRNSSuspension - Itaconix Plc
29th Jun 20187:30 amRNSSuspension of Share Trading and Financing Update
30th May 201810:00 amRNSOperational Update
16th May 20187:00 amRNSJoint marketing effort defined with AkzoNobel
16th Apr 20187:25 amRNSQ1 2018 Trading Update
13th Feb 20187:00 amRNSTrading Update
1st Feb 20187:00 amRNSBlock listing Interim Review
25th Jan 20187:00 amRNSLicence and assignment agreement with tremco
16th Oct 20179:00 amRNSSocietà Chimica Bussi investing in capacity
18th Sep 20177:00 amRNSInterim Results
5th Sep 20179:04 amRNSBio-based chelates for the detergents industry
26th Jul 20172:00 pmRNSFirst Bio-based Polymer Application Agreement
10th Jul 20177:00 amRNSBlock listing Interim Review
1st Jun 20171:19 pmRNSGrant of options
25th May 201712:42 pmRNSResult of AGM
18th May 20177:00 amRNSOperational Update
26th Apr 201711:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.